Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.22USD
23 Feb 2018
Change (% chg)

$0.05 (+1.58%)
Prev Close
$3.17
Open
$3.20
Day's High
$3.26
Day's Low
$3.18
Volume
11,292
Avg. Vol
36,828
52-wk High
$5.10
52-wk Low
$3.00

Chart for

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.85
Market Cap(Mil.): $200.04
Shares Outstanding(Mil.): 52.37
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Nymox Announces U.S. NDA For Fexapotide For BPH

* SAYS ‍RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR FEXAPOTIDE FOR BPH​ WILL BE SUBMITTED LATER IN 2018 Source text for Eikon: Further company coverage:

05 Feb 2018

BRIEF-Nymox Reports 5-Yr Results From Prostate Cancer Study Of Fexapotide Triflutate In 146 U.S. Men

* NYMOX REPORTS 5-YEAR RESULTS FROM PROSPECTIVE RANDOMIZED CONTROLLED PROSTATE CANCER STUDY OF FEXAPOTIDE TRIFLUTATE IN 146 U.S. MEN

22 Jan 2018

BRIEF-Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing‍​

* Nymox Pharmaceutical Corp qtrly loss per share $0.09 - SEC filing‍​ Source text: (http://bit.ly/2j7iBgX) Further company coverage:

06 Nov 2017

BRIEF-Nymox Pharmaceutical says ‍European member states accepted MAA​ for fexapotide triflutate

* Says ‍European member states for Nymox's MAA for fexapotide triflutate for treatment of benign prostatic hyperplasia accepted co's MAA​ Source text for Eikon: Further company coverage:

14 Sep 2017

BRIEF-Nymox Pharmaceutical postpones September 16 AUA meeting

* Says September 16 AUA meeting in Amelia Island, Florida postponed due to hurricane disaster in Florida​ Source text for Eikon: Further company coverage:

11 Sep 2017

Earnings vs. Estimates